XML 28 R18.htm IDEA: XBRL DOCUMENT v3.25.2
Note 9 - Cash, Cash Equivalents, Investments and Restricted Cash
6 Months Ended
Jun. 30, 2025
Notes to Financial Statements  
Financial Instruments Disclosure [Text Block]

9. CASH, CASH EQUIVALENTS, INVESTMENTS AND RESTRICTED CASH

 

The following is a summary of the Company’s cash, cash equivalents and debt investments (in thousands):

 

  

June 30,

 

December 31,

  

2025

 

2024

Cash

 $414,800  $679,949 

Money market funds

  372,582   11,867 

U.S. treasuries and government agency bonds

  177,311   - 

Certificates of deposit

  181,384   164,418 

Corporate debt securities

  -   6,712 

Auction-rate securities backed by student-loan notes

  74   148 

Total

 $1,146,151  $863,094 

 

  

June 30,

 

December 31,

  

2025

 

2024

Reported as:

        

Cash and cash equivalents

 $787,382  $691,816 

Short-term investments

  358,695   171,130 

Investment within other long-term assets

  74   148 

Total

 $1,146,151  $863,094 

 

The following table summarizes the contractual maturities of the short-term and long-term available-for-sale investments as of June 30, 2025 (in thousands):

 

  

Amortized Cost

 

Fair Value

Due in less than 1 year

 $261,048  $261,027 

Due in 1 - 5 years

  97,668   97,668 

Due in greater than 5 years

  75   74 

Total

 $358,791  $358,769 

 

Gross realized gains and losses recognized on the sales of available-for-sale investments were not material for the periods presented.

 

The following tables summarize the unrealized gain and loss positions related to the available-for-sale investments (in thousands):

 

  

June 30, 2025

  

Amortized Cost

 

Unrealized Gains

 

Unrealized Losses

 

Fair Value

Money market funds

 $372,582  $-  $-  $372,582 

Certificates of deposit

  181,384   -   -   181,384 

U.S. treasuries and government agency bonds

  177,332   3   (24)  177,311 

Auction-rate securities backed by student-loan notes

  75   -   (1)  74 

Total

 $731,373  $3  $(25) $731,351 

 

  

December 31, 2024

 
  

Amortized Cost

  

Unrealized Losses

  

Fair Value

 

Money market funds

 $11,867  $-  $11,867 

Certificates of deposit

  164,418   -   164,418 

Corporate debt securities

  6,779   (67)  6,712 

Auction-rate securities backed by student-loan notes

  150   (2)  148 

Total

 $183,214  $(69) $183,145 

 

 

The following tables present information about the available-for-sale investments that had been in a continuous unrealized loss position for less than 12 months and for greater than 12 months (in thousands):

 

  

June 30, 2025

  

Less than 12 Months

 

Greater than 12 Months

 

Total

  

Fair Value

 

Unrealized Losses

 

Fair Value

 

Unrealized Losses

 

Fair Value

 

Unrealized Losses

U.S. treasuries and government agency bonds

 $128,607  $(24) $-  $-  $128,607  $(24)

Auction-rate securities backed by student-loan notes

  -   -   74   (1)  74   (1)

Total

 $128,607  $(24) $74  $(1) $128,681  $(25)

 

  

December 31, 2024

 
  

Greater than 12 Months

  

Total

 
  

Fair Value

  

Unrealized Losses

  

Fair Value

  

Unrealized Losses

 

Corporate debt securities

 $6,712  $(67) $6,712  $(67)

Auction-rate securities backed by student-loan notes

  148   (2)  148   (2)

Total

 $6,860  $(69) $6,860  $(69)

 

An impairment exists when the fair value of an investment is less than its amortized cost basis. As of June 30, 2025 and December 31, 2024, the Company did not consider the impairment of its investments to be a result of credit losses. The Company typically invests in highly rated securities, with the primary objective of minimizing the potential risk of principal loss. The Company’s investment policy generally requires securities to be investment grade and limits the amount of credit exposure to any one issuer. When evaluating a debt security for impairment, management reviews factors such as the Company’s intent to sell, or whether it will more likely than not be required to sell, the security before recovery of its amortized cost basis, the extent to which the fair value of the security is less than its cost, the financial condition of the issuer and the credit quality of the investment.

 

Restricted Cash

 

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheets to the amounts reported on the Condensed Consolidated Statements of Cash Flows (in thousands):

 

  

June 30,

 

December 31,

  

2025

 

2024

Cash and cash equivalents

 $787,382  $691,816 

Restricted cash included in other long-term assets

  142   125 

Total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Statements of Cash Flows

 $787,524  $691,941